MAPK12 and Alzheimer disease: Based on expression levels, nine genes—NRG3, IL1RAP, PMAIP1, STRADA, SGK3, LAMTOR4, MAPK12, PHB, and GRB2—separated AD patients into low- and high-risk groups with different disease survival (P < 0.05).